Institutional Ownership
Agios Pharmaceuticals Inc
CUSIP 00847X104COMAGIOQ1 2026
13D / 13G Filings
61
Schedule 13D/13G on record
Beneficial Filers
20
Distinct reporting persons
Largest Stake
12.9%
Max % of class reported
Institutional Holders
225
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
61 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Armistice Capital, LLC | 13G | 5.2% | 3.04M | SEC |
| 2 | Feb 9, 2026 | Farallon Capital Partners, L.P. | 13G/A | 8.8% | 5.16M | SEC |
| 3 | Feb 9, 2026 | State Street Corporation | 13G | 5.3% | 3.11M | SEC |
| 4 | Dec 5, 2025 | Bellevue Group AG | 13G/A | — | — | SEC |
| 5 | Nov 14, 2025 | Paradigm Biocapital Advisors LP | 13G/A | 4.9% | — | SEC |
| 6 | Aug 28, 2025 | Paradigm Biocapital Advisors LP | 13G | 5.2% | — | SEC |
| 7 | Jul 17, 2025 | Blackrock, Inc. | 13G/A | 7.8% | 4.51M | SEC |
| 8 | Jul 7, 2025 | Bellevue Group AG | 13G | 6.1% | 3.52M | SEC |
| 9 | Jun 13, 2025 | Bb Biotech AG | 13G/A | — | — | SEC |
| 10 | Feb 14, 2025 | Bb Biotech AG | 13G/A | 6.2% | 3.52M | SEC |
51 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Agios Pharmaceuticals Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 5.75M | $194.69M |
| 2 | Farallon Capital Management LLC | 5.68M | $192.29M |
| 3 | State Street Corp | 3.36M | $113.72M |
| 4 | Armistice Capital, LLC | 2.72M | $91.88M |
| 5 | D. E. Shaw & Co., Inc. | 2.68M | $90.70M |
| 6 | Lynx1 Capital Management LP | 2.61M | $88.35M |
| 7 | Erste Asset Management Gmbh | 2.70M | $80.09M |
| 8 | Bnp Paribas Asset Management Holding S.A. | 1.58M | $53.48M |
| 9 | Nomura Asset Management International Inc. | 1.49M | $50.56M |
| 10 | Geode Capital Management, LLC | 1.47M | $49.67M |